Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma, Inc. (TBPH) Capital Expenditures (2013 - 2025)

Updated

Theravance Biopharma (TBPH) recorded Capital Expenditures of $8,000 in Q4 2025, down 95.8% from $190,000 a year earlier.

Analysis

Theravance Biopharma, Inc. (TBPH) Capital Expenditures (2013 - 2025) Analysis & Trends

For FY2025, Theravance Biopharma reported Capital Expenditures of $42,000, down 87.3% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -63.6% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $332,000 in FY2024 (-86.7%), $2.49 million in FY2023 (+335.0%), $572,000 in FY2022 (-83.2%) and $3.41 million in FY2021 (-48.5%).
  • The Q4 2025 figure is the lowest quarterly Capital Expenditures since Q3 2022.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 654.0% in Q2 2023, against a decline of 95.8% in Q4 2025 at the low end.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 8,000.00
Dec 31, 2024 190,000.00
Sep 30, 2024 15,000.00
Jun 30, 2024 36,000.00
Mar 31, 2024 91,000.00
Dec 31, 2023 677,000.00
Sep 30, 2023 21,000.00
Jun 30, 2023 852,000.00
Mar 31, 2023 938,000.00
Dec 31, 2022 266,000.00
Sep 30, 2022 -57,000.00
Jun 30, 2022 113,000.00
Mar 31, 2022 250,000.00
Dec 31, 2021 444,000.00
Sep 30, 2021 1.04 Mn
Jun 30, 2021 156,000.00
Mar 31, 2021 1.77 Mn
Dec 31, 2020 1.24 Mn
Sep 30, 2020 2.05 Mn
Jun 30, 2020 2.37 Mn
API Access

Theravance Biopharma, Inc. Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TBPH&period=max&api_key=YOUR_API_KEY